CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-25 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +32,500 | 32,500 | ||
| 2015-09-25 | MCKEARN THOMAS J President, R&D | Grant or award · Stock Option (right to purchase) | +37,500 | 37,500 | ||
| 2015-09-25 | Guerin Mark Patrick Chief Accounting Officer | Grant or award · Stock Option (right to purchase) | +17,500 | 17,500 | ||
| 2015-09-25 | Fruchtman Steven M Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +40,000 | 40,000 | ||
| 2015-09-25 | Maniar Manoj SVP - Product Development | Grant or award · Stock Option (right to purchase) | +40,000 | 40,000 | ||
| 2015-06-15 | Hoffman Michael B Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2015-06-15 | Reddy E Premkumar Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2015-06-15 | GROOPMAN JEROME Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2015-06-15 | MEHTA VIREN Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2015-06-15 | Bienen Henry S Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2015-06-15 | VANLENT ANNE Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2015-05-06 | Baxter Healthcare SA 10% owner | Other disposition | −2,603,295 | 0 | ||
| 2015-04-20 | Fruchtman Steven M Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +35,000 | 35,000 | ||
| 2015-04-16 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +32,500 | 32,500 | ||
| 2015-04-16 | Guerin Mark Patrick Chief Accounting Officer | Grant or award · Stock Option (right ot purchase) | +15,000 | 15,000 | ||
| 2015-04-16 | MCKEARN THOMAS J President, R&D | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2015-04-16 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to buy) | +87,500 | 87,500 | ||
| 2014-12-18 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +175,000 | 175,000 | ||
| 2014-12-18 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +65,000 | 65,000 | ||
| 2014-12-18 | MCKEARN THOMAS J President, R&D | Grant or award · Stock Option (right to purchase) | +75,000 | 75,000 |
Page 20 of 23 · 449 trades